Interrad Medical, a Minneapolis, MN firm, won FDA clearance for the catheter that features company’s SecurAcath device, a system that grabs to subcutaneous tissue to anchor and secure the central line catheter.
The SecurAcath System utilizes a small anchor that deploys in the subcutaneous tissue just beneath the skin to hold an indwelling catheter securely in place. There are over 12 million venous access catheters placed each year worldwide. Currently, catheters are secured on the surface of a patient’s skin using sutures or adhesive devices.
The SecurAcath System offers significant advantages over current securement methods. The SecurAcath system is designed to improve catheter securement by decreasing catheter maintenance time and related costs, reducing catheter-related infections by improving cleaning of catheter exit site and minimizing catheter motion, decreasing skin surface issues, and eliminating needle stick injuries that may occur when suturing catheters.
The Company is currently developing a stand-alone SecurAcath device that can be used with virtually any indwelling catheter. The stand-alone SecurAcath is being designed to work with all PICC, CVC, dialysis and drainage catheters.
Product page: SecurAcath
Press release: Interrad Medical Receives FDA Clearance of World’s First Catheter with Subcutaneous Securement System (.pdf)…